Sign In
Buy RTX
$180.99
+1.58 (+0.88%)
At Close: Jun 05, 2026
RTX Chairman and CEO to present at the 2025 Bernstein Strategic Decisions Conference
08:00am, Wednesday, 14'th May 2025
ARLINGTON, Va. , May 14, 2025 /PRNewswire/ -- RTX (NYSE: RTX) Chairman and CEO Chris Calio will speak at the 2025 Bernstein Strategic Decisions Conference on Wednesday, May 28 at 11:00 a.m.
RTX's PhantomStrike Radar Catches Spotlight: Should You Buy the Stock Now?
02:35pm, Tuesday, 13'th May 2025
Investors interested in RTX stock should wait for a better entry point, considering its premium valuation and downward revision in earnings estimates.
LMT Vs. RTX Vs. NOC: One Of These 'Golden Dome' Defense Stocks Is About To Make A Golden Cross
10:40am, Tuesday, 13'th May 2025
In the high-stakes race to shape America's next-gen missile shield, Wall Street's "Golden Dome" trio – Northrop Grumman Corp NOC, Lockheed Martin Corp LMT and RTX Corp RTX – are all chasing glory.
I Prefer Lockheed Martin Over RTX Amid Military Expenditure Surge
02:08pm, Tuesday, 06'th May 2025
Since my last analysis, two key catalysts have been evolving around LMT and RTX stock. The unprecedented rise in global military expenditure and the efforts from DOGE (Department of Government Efficie
HII or RTX: Which Is the Better Value Stock Right Now?
12:45pm, Tuesday, 06'th May 2025
Investors interested in Aerospace - Defense stocks are likely familiar with Huntington Ingalls (HII) and RTX (RTX). But which of these two stocks is more attractive to value investors?
RTX's Raytheon completes first flight test for PhantomStrike radar
09:00am, Tuesday, 06'th May 2025
Next-generation radar provides superior threat detection ONTARIO, Calif. , May 6, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, has successfully completed the first flight test of its Ph
RTX's Raytheon demonstrates critical software system to improve decision making in airspace deconfliction and mission planning
08:00am, Tuesday, 06'th May 2025
AI-enabled software provides real-time common operational views and a strategic advantage over adversaries FORT IRWIN, Calif. , May 6, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, succ
RTX Board of Directors Increases Quarterly Cash Dividend
04:15pm, Thursday, 01'st May 2025
ARLINGTON, Va. , May 1, 2025 /PRNewswire/ -- RTX (NYSE: RTX) announced today that its Board of Directors declared a dividend of 68 cents per outstanding share of RTX common stock, which represents an
Trump says IBM and Raytheon might get contract to modernize air traffic controller system
12:11pm, Wednesday, 30'th Apr 2025
President Donald Trump said on Wednesday that the companies Raytheon Technologies and IBM may get the contract to modernize the nation's air traffic controller system.
Is Trending Stock RTX Corporation (RTX) a Buy Now?
10:01am, Tuesday, 29'th Apr 2025
RTX (RTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Defense Stocks Northrop Grumman and RTX Are Tanking. Is Lockheed Martin a Better Buy for Passive Income?
04:10am, Tuesday, 29'th Apr 2025
Northrop Grumman and RTX fell 12.2% and 8.8%, respectively, on April 22 compared to a 1.9% gain for Lockheed Martin (LMT -0.19%).
Should You Buy, Hold or Sell RTX Stock Post Q1 Earnings Release?
02:26pm, Monday, 28'th Apr 2025
Investors interested in RTX stock should avoid adding it to their portfolio, considering its premium valuation and downward revision in earnings estimates.
Blue Light Special - 2 Dividend Growth Gems We're Buying With Both Hands
07:30am, Friday, 25'th Apr 2025
Volatility is flashing a Blue Light Special in markets. Fear is high, but history says these moments often reward long-term investors the most. I see this uncertainty as an opportunity. When panic str
Uncertainty for Defense Stocks Creates Opportunity for Investors
07:15am, Friday, 25'th Apr 2025
Defense stocks are pulling back following Q1 reports from Lockheed Martin NYSE: LMT, Northrop Grumman NYSE: NOC, and RTX NYSE: RTX. The primary cause is uncertainty, followed by tepid guidance.
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
12:26pm, Thursday, 24'th Apr 2025
BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa.
